PDLIM7 and breast carcinoma: Recently, Arbach and colleagues [32] confirmed the previous results [13] and showed that EBNA-1, an early transcript derived from an open reading frame encoding a 26- to 33-kilodalton protein that is recognized by anti-EA serum (BARF-1), and LMP-1 transcripts were present in 77%, 57% and 20% of the breast cancer cases analyzed, respectively.